EFPIA Newsletter 15 October 2020

Health after COVID-19: spend more but spend smarter     Nathalie Moll for the Parliament Magazine   As we enter the final stretch of 2020, we face a huge dilemma for public health and public finances: how do we manage the massive impact of COVID-19 and the increasing burden of chronic diseases without bankrupting public finances? There is a growing recognition of the urgent need to invest more in making our health systems more resilient, and that strategic investments in healthcare infrastructures can play an important part in Europe’s economic recovery. Read more →

News     15 October 2020 Strengthening health systems through smart spending EFPIA has developed a number of policy recommendations for national and European policy-makers to inform a discussion... Read more →         14 October 2020 Biopharmaceutical industry support EU regulators exceptional transparency measures And call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making... Read more →

19 Conversations | The EFPIA podcast series     14 October 2020 Podcast: Who decides the price of a medicine? Welcome to 19 conversations Read more →

Videos

	What is a rolling review? EMA has started the rolling review of COVID-19 vaccines. What is a rolling review? We've asked it to our experts: Sini Eskola, Director, Team Leader, Regulatory, Drug development and Manufacturing, and Anna Czwarno, Senior Manager Vaccines Europe		Are we spending smart in healthcare? According to the OECD, 20% of healthcare expenditure is spent inefficiently, making no meaningful contribution to patients’ outcomes. Smart healthcare spending will allow us to improve health outcomes while not increasing overall costs, or even create savings in the long-term that can be reinvested for better health.

Events     22 OCT 2020   Everything You Always Wanted to Know About Drug Shortages (But were afraid to ask)... Virtual event How can we prevent drug shortages? First-hand insights from the supply chain Learn more →       26 OCT 2020   NEW DATES - EU Health Summit 2020 Virtual event The EU Health Coalition is delighted to announce the second edition of the EU Health Summit. Learn more →

	30 OCT 2020			Orphan Medicines: how to sustain innovation in an area of high unmet need? Virtual event For every case where a new treatment has been developed there are however many more rare diseases that still need treatment... Learn more →

	09 NOV 2020			Neuroscience Virtual Partnering Virtual event Neurological disorders are one of the most feared diseases in the world – they affect almost a billion people worldwide... Learn more →

	10 NOV 2020			IMI Stakeholder Forum 2020 Virtual event The theme this year is 'Broader horizons: growing Europe’s health partnership'. Learn more →

	16 NOV 2020			Clinical Trial Disclosure & Data Transparency Conference Virtual event Organised by DIA Learn more →

What we are reading To overcome COVID-19, we need to show leadership on seasonal flu vaccination 14 October 2020  (Euractiv) Read more → Can the coronavirus bring back Europe’s pharmaceutical factories? 12 October 2020  (Politico) Read more → When will covid-19 vaccines be available? 08 October 2020  (Vaccines Today) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe